ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,560Medicare Part D Prescriptions Filled, Including Refills

Rank: 379 out of 2094

$659K Total Retail Price of All Prescriptions

Rank: 291 out of 2094

595 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
10% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 595 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

5% of this provider’s 595 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

2% of this provider’s 6,834 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 32%.

Prescription Price

$87 was the average price of a prescription from this provider, compared to $78 among peers.

Prescriptions per Patient

13 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
SIMVASTATIN 479 426 1 1
AMLODIPINE BESYLATE 249 219 2 2
METFORMIN HCL 212 195 3 8
ATORVASTATIN CALCIUM 192 169 4 5
LISINOPRIL 189 179 5 7
WARFARIN SODIUM 187 185 6 11
ZOLPIDEM TARTRATE 172 140 7 14
PRAVASTATIN SODIUM 164 148 8 18
METOPROLOL TARTRATE 145 142 9 10
LEVOTHYROXINE SODIUM 133 126 10 3
FUROSEMIDE 131 131 11 6
LOSARTAN POTASSIUM 126 114 12 17
OMEPRAZOLE 123 96 13 4
LIPITOR 109 103 14 39
DICLOFENAC SODIUM 105 92 15 168
METOPROLOL SUCCINATE 104 100 16 9
NEXIUM 100 96 17 16
ADVAIR DISKUS 98 91 18 36
LOSARTAN-HYDROCHLOROTHIAZIDE 98 90 18 52
LOVASTATIN 98 91 18 121
HYDROCODONE-ACETAMINOPHEN 86 77 S3 21 42
LISINOPRIL-HYDROCHLOROTHIAZIDE 86 82 21 55
CIPROFLOXACIN HCL 85 72 23 81
AMOXICILLIN 83 66 24 147
ALENDRONATE SODIUM 83 77 24 30
TAMSULOSIN HCL 83 82 24 29
HYDROCHLOROTHIAZIDE 79 73 27 12
GLYBURIDE 78 67 R 28 95
FENOFIBRATE 72 43 29 104
ALLOPURINOL 70 66 30 50
SERTRALINE HCL 65 56 31 26
ZETIA 64 64 32 79
CLOPIDOGREL 59 57 33 22
PLAVIX 58 55 34 38
CARVEDILOL 57 57 35 19
ISOSORBIDE MONONITRATE ER 54 54 36 57
DIGOXIN 52 52 37 51
SPIRIVA 52 48 37 60
CELEBREX 52 52 37 74
GLIPIZIDE ER 51 41 40 126
PREDNISONE 50 50 41 54
CRESTOR 50 41 41 15
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.